CXCR4 and ovarian carcinoma: Our data suggest that CD44v6-O-MWNTS/DOTAP could significantly improve the delivery and uptake effectiveness of CXCR4 siRNA and clinical drug including Gemcitabine and Oxaliplatin for the treatment of ovarian cancer.